CDC Logo Tuberculosis Information CD-ROM   Image of people
jump over main navigation bar to content area
TB Guidelines
Surveillance Reports
Slide Sets
TB-Related MMWRs and Reports
Education/Training Materials
Ordering Information


U.S. Department of Health and Human Services

jump over right navigation bar
TB Notes 1, 2000
Where We've Been and Where We're Going: Perspectives from CDC's Partners in TB Control
Changes I've Seen
TB Control in New York City: A Recent History
Not by DOT Alone
Baltimore at the New Millennium
From Crickets to Condoms and Beyond
The Denver TB Program: Opportunity, Creativity, Persistence, and Luck
National Jewish: The 100-Year War Against TB
Earthquakes, Population Growth, and TB in Los Angeles County
TB in Alaska
CDC and the American Lung Association/ American Thoracic Society: an Enduring Public/Private Partnership
The Unusual Suspects
The Model TB Prevention and Control Centers: History and Purpose
My Perspective on TB Control over the Past Two to Three Decades
History of the IUATLD
Thoughts about the Future of TB Control in the United States
Where We've Been and Where We're Going: Perspectives from CDC
Early History of the CDC TB Division, 1944-1985
CDC Funding for TB Prevention and Control
Managed Care and TB Control - A New Era
Early Research Activities of the TB Control Division
The First TB Drug Clinical Trials
Current TB Drug Trials: The Tuberculosis Trials Consortium (TBTC)
TB Communications and Education
TB Control in the Information Age
Field Services Activities
TB's Public Health Heroes
Infection Control Issues
A Decade of Notable TB Outbreaks: A Selected Review
International Activities
The Role of CDC's Division of Quarantine in the Fight Against TB in the U.S.
The STOP TB Initiative, A Global Partnership
Seize the Moment - Personal Reflections
Return to Table of Contents

This is an archived document. The links are no longer being updated.

TB Notes 1, 2000

The STOP TB Initiative, A Global Partnership

by Bess Miller, MD, MSc
Associate Director for Science, DTBE

Image 1: Logo of the "Stop TB" initiative

Over the past few decades, when we have looked at the agendas of international health agencies, major donors to the health sector, government health ministries, academia, and civil society, we have wondered, Where is TB? Why is TB on the back burner? The STOP TB Initiative is a global campaign to move TB to the FRONT BURNER.

Why now?

With the arrival last year of the new Director General of the World Health Organization (WHO), Dr. Gro Brundtland, there has been an interest in intensifying the relationship between WHO and its global partners. For a number of diseases, but especially for malaria and TB, WHO has initiated campaigns to join forces with other agencies and donors in the public and private sectors to achieve global health objectives.

Additional factors have added fuel to the sparks of this new campaign. Over the past several years the World Bank has given an unprecedented number of loans to developing countries to strengthen TB control efforts and has established TB as one of its top priority diseases. There has been renewed interest in TB research in the areas of vaccine development, new drug development, and new diagnostics. Large donors such as the Soros and Gates Foundations have shown an interest and commitment to TB control and TB research. The stars are aligned.

In November 1998, at the annual meeting of the International Union Against Tuberculosis and Lung Disease held in Bangkok, Thailand, Dr. Brundtland launched the STOP TB Initiative, a WHO-led global partnership whose mission is to put TB higher on the international public health agenda and to substantially increase the investment in TB worldwide. It aims to increase involvement of international players at all levels, including international health agencies, donor agencies, governments, nongovernmental organizations, professional societies, and community organizations involved in TB at the country level. The focus of the initiative is on the 22 so-called "high-burden" countries which WHO has identified as responsible for approximately 80% of all reported cases of TB in the world. These include India, China, Indonesia, Bangladesh, Pakistan, Nigeria, Philippines, South Africa, Ethiopia (Fed. Democratic Republic of), Viet Nam, Russian Federation, Congo (Democratic Republic), Brazil, Tanzania (United Republic of), Kenya, Thailand, Myanmar, Afghanistan, Uganda, Peru, Zimbabwe, and Cambodia. In addition, countries with extremely high rates of TB, especially those impacted by the HIV epidemic, will be targeted.

The STOP TB Initiative will focus attention on addressing the specific constraints to action on TB identified at the London Ad Hoc Committee Meeting on the Global TB Epidemic held in March 1998. The needs identified at this meeting include political will and commitment, human resource development, a secure supply of quality anti-TB drugs, research, financing, organization and management, information systems, and health sector reform.

The founding partners of the STOP TB Initiative are the WHO, the Royal Netherlands TB Association (KNCV), the International Union Against TB and Lung Disease, the World Bank, the American Lung Association, the American Thoracic Society, and the Centers for Disease Control and Prevention. New partners include UNICEF, UNAIDS, the National Institutes of Health, the Japan Anti-TB Association, the Norwegian Heart and Lung Association, the Canadian International Development Agency, the Soros Foundation, and the Rockefeller Foundation. Many, many others are joining. The tremendous energy and inspiration these new partners bring to the Initiative cannot be overstated.

Current efforts of the STOP TB Initiative are directed at the following four areas:

  1. the creation of a global drug supply facility to provide universal availability of quality TB drugs;
  2. the development of a global partnership agreement to catalyze and secure public agreements among donor agencies and high-burden countries on specific steps to be taken to control TB;
  3. the co-sponsorship of an initiative to develop new drugs for TB; and
  4. the co-sponsorship with the Government of the Netherlands of a Ministerial Conference in March 2000.
This conference brought together the ministers of health as well as of finance, development, and planning from the highest burden countries to set the stage for expanded country action against TB across sectors of government and society.

While many efforts are underway at the "global" level, TB control efforts take place at the local level, and it is at this level that we will concentrate future efforts. This past summer, the Initiative sponsored a series of regional workshops with the highest burden countries to identify constraints to TB control at the country level. Suggestions for the STOP TB Initiative made at these workshops included the following activities:

  1. expand beyond traditional partners for TB control;
  2. strengthen advocacy;
  3. develop a social mobilization campaign; and
  4. increasem operations research in affected countries.

CDC is actively participating in the STOP TB Initiative and is represented on the Steering Committee (Bess Miller, Associate Director for Science and Carl Schieffelbein, Deputy Director for Special Projects, DTBE), as well as the Secretariat in Geneva (Mark Fussell, Public Health Advisor, DTBE).

Yes, TB is on the front burner at last, and we plan to keep it there!


Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination -

Please send comments/suggestions/requests to:, or to
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333